SXI Life Sciences
7.139,76
PKT
+102,44
PKT
+1,46
%
Werbung
Analysen zu SXI Life Sciences-Werten
Datum | Rating | Analyst | |
---|---|---|---|
02.01.19 | Roche overweight | JP Morgan Chase & Co. | |
02.01.19 | Novartis Underweight | JP Morgan Chase & Co. | |
14.12.18 | Novartis Equal-Weight | Morgan Stanley | |
14.12.18 | Roche overweight | Morgan Stanley | |
14.12.18 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
14.12.18 | Roche Neutral | Merrill Lynch & Co., Inc. | |
14.12.18 | Novartis buy | Merrill Lynch & Co., Inc. | |
13.12.18 | Novartis Conviction Buy | Goldman Sachs Group Inc. | |
11.12.18 | Novartis buy | Jefferies & Company Inc. | |
11.12.18 | Roche buy | Jefferies & Company Inc. | |
10.12.18 | Roche Neutral | UBS AG | |
10.12.18 | Roche Hold | Deutsche Bank AG | |
10.12.18 | Novartis Hold | Deutsche Bank AG | |
10.12.18 | Novartis buy | Kepler Cheuvreux | |
10.12.18 | Novartis Underweight | Barclays Capital | |
08.12.18 | Novartis Underweight | Barclays Capital | |
05.12.18 | Roche overweight | JP Morgan Chase & Co. | |
03.12.18 | Roche buy | Baader Bank | |
03.12.18 | Roche overweight | JP Morgan Chase & Co. | |
28.11.18 | Novartis Neutral | JP Morgan Chase & Co. | |
28.11.18 | Novartis Hold | HSBC | |
21.11.18 | Novartis Neutral | UBS AG | |
19.11.18 | Novartis Conviction Buy | Goldman Sachs Group Inc. | |
06.11.18 | Novartis Neutral | JP Morgan Chase & Co. | |
02.11.18 | Roche overweight | JP Morgan Chase & Co. | |
01.11.18 | Roche overweight | JP Morgan Chase & Co. | |
01.11.18 | Roche buy | Baader Bank | |
25.10.18 | Novartis Hold | HSBC | |
23.10.18 | Roche Neutral | UBS AG | |
22.10.18 | Novartis Neutral | JP Morgan Chase & Co. | |
22.10.18 | Roche overweight | JP Morgan Chase & Co. | |
22.10.18 | Novartis Neutral | Goldman Sachs Group Inc. | |
22.10.18 | Roche Hold | Deutsche Bank AG | |
22.10.18 | Novartis Hold | Deutsche Bank AG | |
19.10.18 | Novartis Hold | Baader Bank | |
19.10.18 | Novartis Neutral | Credit Suisse Group | |
18.10.18 | Novartis buy | CFRA | |
18.10.18 | Roche overweight | JP Morgan Chase & Co. | |
18.10.18 | Roche Hold | Deutsche Bank AG | |
18.10.18 | Novartis buy | Jefferies & Company Inc. |